| Trial ID: | L3261 |
| Source ID: | NCT01019486
|
| Associated Drug: |
Regadenoson Myocardial Perfusion Imaging
|
| Title: |
Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)
|
| Acronym: |
RABIT1D
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01019486/results
|
| Conditions: |
Coronary Artery Disease|Type 1 Diabetes Mellitus
|
| Interventions: |
DRUG: Regadenoson myocardial perfusion imaging|DRUG: Regadenoson MRI myocardial blood flow
|
| Outcome Measures: |
Primary: Coronary Blood Flow Assessment With Regadenoson Stress by Cardiac MRI Between Non-diabetic and Type 1 Diabetic Subjects., Measurement of Myocardial blood flow measurements (MBF) and myocardial perfusion index obtained from 6 regions within the mid ventricular LV short axis slice., 1 month | Secondary: Measured Coronary Blood Flow is Directly Correlated With Coronary Flow Reserve Measured Invasively in the Cardiac Catheterization Laboratory After Regadenoson Pharmacologic Stress., Regional coronary blood flow reserve (CFR) in a target artery (defined on MPI study) compared to flow in a less diseased atherosclerotic vessel following vasodilator response to intravenously administered regadenoson., within 6 months|Myocardial Perfusion Index, Myocardial perfusion indices radionuclide stress and rest images and were obtained from 6 regions within the mid ventricular LV short axis slice. Each was corrected for decay and standardized to a 30 mCi administered dose for each part of a two day study., 1 month
|
| Sponsor/Collaborators: |
Sponsor: University of Colorado, Denver
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
26
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2009-11
|
| Completion Date: |
2011-12
|
| Results First Posted: |
2015-12-14
|
| Last Update Posted: |
2015-12-14
|
| Locations: |
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, 80045, United States|University of Colorado Denver, Aurora, Colorado, 80045, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|University Hospital, the University of Colorado Health Sciences Center, Denver, Colorado, 80262, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01019486
|
